Hangzhou Zhongmei Huadong Pharmaceutical Discontinued
FDA Approved Drugs

Hangzhou Zhongmei Huadong Pharmaceutical Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 11
  • Latest Approval Date Aug 19, 2024
  • Data Source FDA
  • First Approval Date Aug 18, 2020
All
14
View
Discontinued
11
View
RX
3
View
Company Overview

Company

Hangzhou Zhongmei Huadong Pharmaceutical Discontinued

Country

China

Website

Visit Website

Email

sales@eastchinapharm.com

Social Profiles

Company Snapshot

Hangzhou Zhongmei Huadong Pharmaceutical Discontinued

No. 866, Moganshan Road Hangzhou, 310011

China

www.zmhdpharm.com/ sales@eastchinapharm.com View on Map
FDA Approved Drug Records ( 11 records )
2020
18 Aug
Discontinued Application: 213821

Drug Name

ACARBOSE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-08-18

213821 / 1

Active Ingredient

ACARBOSE

Application Number

213821

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-08-18

Regulatory Status

Discontinued

2020
18 Aug
Discontinued Application: 213821

Drug Name

ACARBOSE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-08-18

213821 / 2

Active Ingredient

ACARBOSE

Application Number

213821

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-08-18

Regulatory Status

Discontinued

2020
18 Aug
Discontinued Application: 213821

Drug Name

ACARBOSE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2020-08-18

213821 / 3

Active Ingredient

ACARBOSE

Application Number

213821

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2020-08-18

Regulatory Status

Discontinued

2021
26 Nov
Discontinued Application: 215215

Drug Name

DAPTOMYCIN

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2021-11-26

215215 / 1

Active Ingredient

DAPTOMYCIN

Application Number

215215

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2021-11-26

Regulatory Status

Discontinued

2024
19 Aug
Discontinued Application: 216493

Drug Name

FONDAPARINUX SODIUM

Product Number

1

Dosage Form

-

Strength

2.5MG/0.5ML (2.5MG/0.5ML)

Approval Date

2024-08-19

216493 / 1

Active Ingredient

FONDAPARINUX SODIUM

Application Number

216493

Product Number

1

Dosage Form

-

Strength

2.5MG/0.5ML (2.5MG/0.5ML)

Approval Date

2024-08-19

Regulatory Status

Discontinued

2024
19 Aug
Discontinued Application: 216493

Drug Name

FONDAPARINUX SODIUM

Product Number

2

Dosage Form

-

Strength

5MG/0.4ML (5MG/0.4ML)

Approval Date

2024-08-19

216493 / 2

Active Ingredient

FONDAPARINUX SODIUM

Application Number

216493

Product Number

2

Dosage Form

-

Strength

5MG/0.4ML (5MG/0.4ML)

Approval Date

2024-08-19

Regulatory Status

Discontinued

2024
19 Aug
Discontinued Application: 216493

Drug Name

FONDAPARINUX SODIUM

Product Number

3

Dosage Form

-

Strength

7.5MG/0.6ML (7.5MG/0.6ML)

Approval Date

2024-08-19

216493 / 3

Active Ingredient

FONDAPARINUX SODIUM

Application Number

216493

Product Number

3

Dosage Form

-

Strength

7.5MG/0.6ML (7.5MG/0.6ML)

Approval Date

2024-08-19

Regulatory Status

Discontinued

2024
19 Aug
Discontinued Application: 216493

Drug Name

FONDAPARINUX SODIUM

Product Number

4

Dosage Form

-

Strength

10MG/0.8ML (10MG/0.8ML)

Approval Date

2024-08-19

216493 / 4

Active Ingredient

FONDAPARINUX SODIUM

Application Number

216493

Product Number

4

Dosage Form

-

Strength

10MG/0.8ML (10MG/0.8ML)

Approval Date

2024-08-19

Regulatory Status

Discontinued

2023
17 Apr
Discontinued Application: 210929

Drug Name

TACROLIMUS

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2023-04-17

210929 / 1

Active Ingredient

TACROLIMUS

Application Number

210929

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2023-04-17

Regulatory Status

Discontinued

2023
17 Apr
Discontinued Application: 210929

Drug Name

TACROLIMUS

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-04-17

210929 / 2

Active Ingredient

TACROLIMUS

Application Number

210929

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-04-17

Regulatory Status

Discontinued

2023
17 Apr
Discontinued Application: 210929

Drug Name

TACROLIMUS

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2023-04-17

210929 / 3

Active Ingredient

TACROLIMUS

Application Number

210929

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2023-04-17

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    7 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    14 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
11 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACARBOSE

Application Number

213821

Product Number

1

Active Ingredient

ACARBOSE

Dosage Form

-

Strength

25MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit